The potential of micro- and nanoplastics to exacerbate the health impacts and global burden of non-communicable diseases

Cell Rep Med. 2024 Jun 18;5(6):101581. doi: 10.1016/j.xcrm.2024.101581. Epub 2024 May 22.

Abstract

Non-communicable diseases (NCD) constitute one of the highest burdens of disease globally and are associated with inflammatory responses in target organs. There is increasing evidence of significant human exposure to micro- and nanoplastics (MnPs). This review of environmental MnP exposure and health impacts indicates that MnP particles, directly and indirectly through their leachates, may exacerbate inflammation. Meanwhile, persistent inflammation associated with NCDs in gastrointestinal and respiratory systems potentially increases MnP uptake, thus influencing MnP access to distal organs. Consequently, a future increase in MnP exposure potentially augments the risk and severity of NCDs. There is a critical need for an integrated one-health approach to human health and environmental research for assessing the drivers of human MnP exposure and their bidirectional links with NCDs. Assessing these risks requires interdisciplinary efforts to identify and link drivers of environmental MnP exposure and organismal uptake to studies of impacted disease mechanisms and health outcomes.

Keywords: additives; exposure; global health; inflammation; inflammatory; microplastic; particle.

Publication types

  • Review

MeSH terms

  • Environmental Exposure* / adverse effects
  • Global Burden of Disease
  • Humans
  • Inflammation
  • Microplastics*
  • Nanoparticles / adverse effects
  • Noncommunicable Diseases* / epidemiology

Substances

  • Microplastics